OPA1, a new mitochondrial target in cancer therapy
Authors:
Open Access
- 13 November 2020
- journal article
- editorial
- Published by Impact Journals, LLC in Aging
- Vol. 12 (21) , 20931-20933
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the DrugsFrontiers in Cell and Developmental Biology, 2020
- Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1Cell Metabolism, 2020
- The cell biology of mitochondrial membrane dynamicsNature Reviews Molecular Cell Biology, 2020
- Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax TreatmentCancer Discovery, 2019
- Identification of novel prognosis-related genes associated with cancer using integrative network analysisScientific Reports, 2018
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Angiogenesis in life, disease and medicineNature, 2005